EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action

Nathaniel C Nelson, Rebecca Kogan, Rany Condos, Kerry M Hena

Journal of Clinical Medicine · 19.12.2023 · 13 (1) · 15

DOI: 10.3390/jcm13010015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.12.2023. Verfasst von Nathaniel C Nelson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University, 301 E 17th St Suite 550, New York, NY 10003, U…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcoidosis is a systemic disease with heterogenous clinical phenotypes characterized by non-necrotizing granuloma formation in affected organs. Most disease either remits spontaneously or responds to corticosteroids and second-line disease-modifying therapies. These medications are associated with numerous toxicities that can significantly impact patient quality-of-life and often limit their long-term use. Additionally, a minority of patients experience chronic, progressive disease that proves refractory to standard treatments. To date, there are limited data to guide the selection of alternative third-line medications for these patients. This review will outline the pathobiological rationale behind current and emerging therapeutic agents for refractory or drug-intolerant sarcoidosis and summarize the existing clinical evidence in support of their use.

Schlagwörter

Stichwörter der Autor:innen

fibrosisgranulomarefractorysarcoidosistherapy

Autor:innen und Institutionen

  • Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University, 301 E 17th St Suite 550, New York, NY 10003, USA.

Zitieren

APA

Nelson, N. C., Kogan, R., Condos, R., & Hena, K. M. (2023). Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action. Journal of Clinical Medicine, 13(1), 15. https://doi.org/10.3390/jcm13010015

Vancouver

Nelson NC, Kogan R, Condos R, Hena KM. Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action. Journal of Clinical Medicine. 2023;13(1):15. doi:10.3390/jcm13010015

BibTeX
@article{Nelson2023,
  author = {Nelson, Nathaniel C and Kogan, Rebecca and Condos, Rany and Hena, Kerry M},
  title = {Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {13},
  number = {1},
  pages = {15},
  doi = {10.3390/jcm13010015}
}
Kostenlos starten →